OpenAI, the developer of ChatGPT, hopes to join Singapore's ‘thriving AI ecosystem' with new office
Singapore is set to become a hub for OpenAI as the ChatGPT developer eyes a regional expansion. The Southeast Asian country has 'emerged as a leader in artificial intelligence,' CEO Sam Altman said in a statement, according to CNA. The AI developer hopes to partner with Singapore's 'thriving AI ecosystem,' he added.
The new office will support customers and partners in the Asia-Pacific region, and strengthen relationships with governments, businesses, and institutions. The office plans to hire as many as 10 employees before 2025, reports the Straits Times.
The office is the AI developer's second in Asia, following the opening of a Japan office earlier this year.
OpenAI already has local partnerships in Singapore, including one with ride-hailing firm Grab announced at the end of May. The agreement gives Grab access to OpenAI's technical expertise to develop solutions specific to Southeast Asia. One of Grab's former board members, Oliver Jay, now serves as OpenAI's managing director of international operations.
Singaporeans are some of the heaviest users of ChatGPT on a per capita basis, OpenAI claimed in its Wednesday statement, according to Bloomberg.
In 2019, Singapore became one of the first countries to adopt a national AI strategy. The country not only hopes to attract investments in AI, but also wants to leverage its access to data collected as a hub for goods and services.
Singapore's plan to keep up with AI giants like the U.S. and China is meant to ensure that residents can 'compete on quality,' Simon Chesterman, vice provost at the National University of Singapore, said at the Fortune Brainstorm AI Singapore conference in July.
The country is also taking the lead in ensuring that Southeast Asia is better represented in the digital space through measures like the Southeast Asian Languages in One Network project (SEA-LION), an initiative to build a model that incorporates Southeast Asian languages.
On Wednesday, OpenAI also announced a partnership with AI Singapore, a joint government-academic project to encourage AI adoption. The ChatGPT developer is providing up to $1 million to help 'ensure AI models are better suited to Southeast Asia's diverse languages and cultures.'
This story was originally featured on Fortune.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
36 minutes ago
- Yahoo
Why This Beaten Down Biotech Stock Might Be a Hidden Gem
In the volatile biotech industry, it is easy to overlook small-cap medical device companies, particularly those that are not yet profitable. But every now and then, a company slips under the radar despite having the ideal combination of innovation, market opportunity, and long-term strategic execution. One such company is Alphatec Holdings (ATEC), a medical technology firm specializing in advanced spine surgery solutions. Alphatec uses artificial intelligence (AI) technologies to improve surgical precision, automate signal monitoring, and provide intraoperative analytics. While it is not a pure-play AI company, AI is becoming more integrated into its platform, helping to shape the future of spine surgery. Dear Tesla Stock Fans, Mark Your Calendars for June 22 Nvidia Says Quantum Computing Is Nearing an 'Inflection Point.' Here Are the 3 Best Stocks to Buy Now to Profit. Warren Buffett Loves This Cheap Dividend Stock and So Do Company Insiders Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. With consistent revenue growth, ATEC is gradually gaining traction. Valued at a market capitalization of $1.6 billion, Alphatec stock has risen 21% year to date (YTD), outperforming the S&P 500 Index's ($SPX) gain of 2.2% YTD. Long-term investors who are willing to dig deeper may find this beaten-down growth stock to be a hidden gem. Founded in 1990, Alphatec initially focused on spinal implants and surgical instrumentation. However, it is now reimagining spine surgery as a fully integrated experience, with cutting-edge implants, navigation systems, and surgical software. The company's platform is intended to assist spine surgeons in operating with greater precision, reducing complications, shortening patient recovery times, and collecting intraoperative data for better long-term outcomes. Alphatec has achieved double-digit revenue growth lately, owing to increased surgeon adoption and new product launches. In the first quarter of 2025, total revenue increased 22% year on year to $169 million, with surgical revenue up 24%. Procedure volume is increasing as more surgeons use Alphatec's approaches. The company is quickly becoming a preferred partner for spine surgeons because of its technological capabilities. In Q1, Alphatec experienced an 18% increase in new surgeon adoption. Like most growth companies, Alphatec has yet to turn a profit despite increasing revenues. These losses are largely the result of aggressive reinvestment in growth, research and development (R&D), and surgeon support. During the quarter, the company spent $16.58 million on R&D. Adjusted gross margin reached 70.4% in the quarter. Looking at the firm's consistent revenue growth and margins, profitability may not be far away, especially if the company continues to increase procedure volumes and expand its ecosystem. Adjusted EBITDA stood at $10.5 million in the quarter, up from a $3 million loss in the year-ago quarter. At the end of Q1, Alphatec had $153.2 million in cash and cash equivalents. Management expects adjusted EBITDA of $78 million in 2025, compared to $31 million in the previous year. Analysts covering Alphatec predict that revenue will increase by 20.1% in 2025, in line with management's expectations. Revenue could rise by 18.3% in 2026, with losses gradually declining. The U.S. spine surgery market is large and growing, with a projected value of $20 billion by 2031. Chronic back pain and spinal deformities are on the rise, owing to the aging population and climbing obesity rates. While Alphatec's market share remains small, this allows the company plenty of room to grow. As demand for more precise and less invasive surgeries increases, the few companies like Alphatec with integrated, AI-capable surgical platforms may lead their industry. Of course, growing biotech stocks can be risky. Alphatec faces stiff competition from larger, established players in the medical technology industry, such as Intuitive Surgical (ISRG), Stryker (SYK), and Medtronic (MDT). Furthermore, continued losses may necessitate additional capital raises or risk share dilution. For a company in its early growth stages, however, these risks are manageable, especially given Alphatec's strong traction with both products and customers. Its sole focus on spine surgery also distinguishes the firm as an expert in its field, which is also known as a moat. Still, because Alphatec is a growing biotech company, ATEC is better suited for aggressive investors willing to hold the stock until it reaches its full potential. Last month, H.C. Wainwright analyst Sean Lee reiterated his 'Buy' rating on ATEC stock, citing the company's strong Q1 2025 performance and growth trajectory. Lee emphasized Alphatec's improved profitability, citing consecutive quarters of positive adjusted EBITDA and a decrease in cash burn. The company now expects positive cash flow by year-end, with a projected increase in adjusted EBITDA for 2025. Despite regulatory and financial risks, Lee believes Alphatec is well-positioned for long-term growth. Backed by valuation metrics like EV-to-sales and DCF analysis, Lee set a 12-month price target of $20 per share. Separately, Barclays also maintained a 'Buy' rating on ATEC with a price target of $21. Recently, Lake Street initiated coverage of ATEC stock with a price target of $18 and a 'Buy' rating. According to the analyst, Alphatec is the only major spine company fully committed to improving spinal surgery outcomes, while the rest of the industry appears disorganized or uncertain. Lake Street also predicts that Alphatec's exceptional growth rate will continue. On Wall Street, ATEC is rated a 'Strong Buy' by consensus. Of the 11 analysts covering the stock, nine have rated it a 'Strong Buy' while one analyst recommends a 'Moderate Buy' rating and one rates the stock a 'Hold.' Based on its mean price target of $18.32, Wall Street expects the stock to climb as high as 66% from current levels. Furthermore, the Street-high estimate of $22.50 per share implies potential upside of nearly 105% over the next 12 months. On the date of publication, Sushree Mohanty did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Why T-Mobile Stock Fell Today
A big T-Mobile investor sold a large block of stock. However, it's no reason for T-Mobile shareholders to panic. The investor likely needs the money for other investments. 10 stocks we like better than T-Mobile US › Shares of telecom leader T-Mobile US (NASDAQ: TMUS) sank as much as 4.6% today, before rebounding to a 4% decline as of 1 p.m. ET. Shares fell on news that major investor SoftBank sold a large block of T-Mobile shares. However, looking at SoftBank's other business endeavors, it's probably not too much of a concern for T-Mobile shareholders. Today, Bloomberg reported that SoftBank sold about $4.8 billion shares of T-Mobile, totaling 21.5 million shares at a price of $224 per share. That's about a 3% discount to T-Mobile's closing price yesterday. Often, when an investor wants to sell a large block of shares quickly, that investor will have to sell at a discount to move that much stock. The move amounted to about 25% of SoftBank's stake in T-Mobile, which SoftBank acquired when T-Mobile acquired Sprint in 2020, in which SoftBank had invested heavily. It's not a big guess as to why SoftBank is selling shares; Softbank made an agreement to invest $10 billion in OpenAI back on April 1, and will also invest up to $30 billion in the current artificial intelligence (AI) leader by the end of this year if certain conditions are met. That massive new investment in OpenAI, and likely other AI companies, too, means SoftBank will most likely have to sell off some of its big "winners," such as T-Mobile, which is Softbank's largest holding of which it does not own a majority stake, and Arm Holdings, which is consolidated with Softbank's financials, due to Softbank's 90% current ownership. Needless to say, today's decline doesn't have anything to do with T-Mobile's operations, which seem rock-solid. This also isn't the first time Softbank has sold shares. Exactly five years ago after the acquisition of Sprint, Softbank sold T-Mobile shares in June 2020 in the low-$100 range. T-Mobile's stock has since doubled, and it's initiated a growing dividend. Before you buy stock in T-Mobile US, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and T-Mobile US wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $660,821!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $886,880!* Now, it's worth noting Stock Advisor's total average return is 791% — a market-crushing outperformance compared to 174% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 Billy Duberstein and/or his clients have positions in T-Mobile US. The Motley Fool recommends T-Mobile US. The Motley Fool has a disclosure policy. Why T-Mobile Stock Fell Today was originally published by The Motley Fool
Yahoo
an hour ago
- Yahoo
Marvell is a 'very high growth' AI player: BofA analyst
Marvell Technology (MRVL) stock gains after the semiconductor tech company hosted its custom artificial intelligence (AI) chip event, showcasing its AI plans and capacity. Following the event, Bank of America (BAC) analysts lifted their price target for the stock to $90 from $80. BofA Securities senior semiconductor analyst Vivek Arya joins Market Domination to explain what drove the price target increase and why he's bullish on Marvell as an AI player. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.
